Kursinformation
Für dieses Unternehmen ist kein Kurs-Chart verfügbar.
()
Aktuelle News
News Funktionen
Weitere Funktionen
9 August 2022
13:00
Corporate
EN
Kadimastem
Corporate
EN
Kadimastem Receives US Patent For Amyotrophic Lateral Sclerosis (ALS) Treatment
8 Juni 2022
13:00
Corporate
EN
Kadimastem
Corporate
EN
Kadimastem and Implant Therapeutics, Inc. Sign an Evaluation Agreement Towards the Potential Licensing of “Immune Evasive” Cells
30 Mai 2022
15:10
Corporate
EN
Kadimastem
Corporate
EN
Kadimastem Awarded Patent in Japan for AstroRx® For ALS and Drug Screening
18 Mai 2022
13:00
Corporate
EN
Kadimastem
Corporate
EN
Kadimastem Expands R&D Program to Include Multiple Sclerosis
3 März 2022
14:05
Corporate
EN
Kadimastem
Corporate
EN
Kadimastem Receives Grant for a Total Budget of NIS 10 Million ($3.1 million) from the Israeli Innovation Authority
13 Dezember 2021
13:00
Corporate
EN
Kadimastem
Corporate
EN
Kadimastem Announces the Approval of a 4M NIS ($1.29M) Budget from the Israel Innovation Authority